This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Investigation on the Sustained Effect of Anthocyanins on Endothelial Function in Postmenopausal Women

Sponsored by Heinrich-Heine University, Duesseldorf

About this trial

Last updated 10 years ago

Study ID

Anthocyanins

Status

Completed

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
50+ Years
Female
Female

Trial Timing

Ended 10 years ago

What is this trial about?

Anthocyanins are the most common polyphenols in berries and red wine, along with other flavonoids, phenolic acids, minerals and vitamins. Anthocyanins are extensively metabolized and they are transformed into glucuronides and phenolic acids. The investigators have recently shown that the acute consumption of blueberries leads to an increase in endothelium-dependent vasodilation measured as flow-mediated dilatation (FMD) in young male volunteers. There were significant correlations of these effects with the plasma concentration of phenolic acids and anthocyanin metabolites. Therefore, the present study aims at understanding to which extent the anthocyanins contained in berries are related with positive effects in endothelial function. A large part of the absorbed anthocyanin circulate in the blood in as methyl, glucuronyl and sulfate metabolites, as well as phenolic acids. The formation of these metabolites begins right as early as 2h after consumption due to metabolism at the small intestine and a second plasmatic peak occurs around 6h due the metabolism of colonic bacteria. Whether and which metabolites are associated with biological effects and the mechanisms underlying this effect remains unclear.

What are the participation requirements?

Yes

Inclusion Criteria

- Post-menopausal female subjects without clinical signs or symptoms of cardiovascular disease, no menstruation cycle for more than 1 year, postmenopausal status conformed by female hormone analysis

- > 50 years

No

Exclusion Criteria

- cardiovascular disease

- acute inflammation

- cardiac arrhythmia

- renal failure

- heart failure (NYHA II-IV)

- diabetes mellitus

- C-reactive protein > 0.5 mg/dL

- malignant disease

- hypotension (≤100 / 60 mm Hg)

Locations

Location

Status